Unit 8 and 9 Flashcards
Short acting insulin-regular (Humulin R, Novalin R)
onset within 30-60 min, peaking in 2-4 hours, duration of 5-7 hours
Intermediate acting: NPH (Humalin N, Novalin N)
onset within 1-2 hours, peaking in 4-12 hours, duration of 18-24 hours
Mixed- NPH 70%/ regular 30%, or NPH/regular 50%
Onset of 0.5-1 hours, peaking in 1.5-16 hours, duration of 24-36 hours.
Rapid acting: insulin lispro (humalog), aspart (novolog), glusisine (apidra)
onset 5-30 min, peaking in 1-3 hours, duration of 3-5 hours
Long acting glargin (lantus), detemir (levemir)
onset 1 hour, no peak, duration about 24 hours.
sulfonylureas:
Glimepride: Mechanism of action: stimulates release of insulin B cells and increased sensitivity to insulin, common adverse effects: weight gain, hypoglycemia, Gi disterss, hepatotoxicity. Contraindications: Hypersensitivity, Type 1 diabetes.
Alpha-Glucosidase inhibitors
Acarbose: Mech of action: blocks breakdown of glucose so it can’t break down in GI, Common side effects: D, flatulence, abdominal distress, borborygmi, anemia (iron), erythema. Contraindications: Inflammatory bowel disease, Type 1 diabetes
Biguanide
metformin- Mechanism of action: lowers hepatic production of glucose, increases the binding of insulin on receptors. common adverse effects: N,V,A,D, abdominal pain, metallic taste, H2O retention. contraindications: no alcohol, kidney functions, type 1, resp. problems.
Glitazones (thiazolidinedones)
Rosiglitazone: Mechanism of actions: improves cell sensitivity to insulin and decreases insulin sensitivity. common side effects: fluid retention and edema, HA, upper resp infections. Contraindications: heart failure, hepatic disease, type 1
Meglitinides
Nateglinide- Mechanism of actions: stimulates the release of insulin from pancreatic islets. common side effects: hypoglycemia, GI problems. Contraindications: Insulin dependent, lactation, Type 1
Incretin therapies
Sitagliptin- mechanism of actions: slows down inactivation of incretin, which stimulates release of insulin. Common adverse effects: HA, D, nasopharyngitis, hypoglycemia, constipation, upper respt tract infections. contraindications: type 1 DKA, renal disorders or failure.
Congenital hypothyroidism
inadequate thyroid hormone at birth, cretanism
primary hypothyroidism
dysfunction of the thyroid gland
secondary hypothyroidism
dysfunction of the pituitary gland
tertiary hypothyroidism
Dysfunction of the hypothalmus